Scientists Honored with Kappa Delta Awards for Advancing Orthopaedic Research

    Four scientists who have made significant contributions to orthopaedic research were honored by the Kappa Delta Foundation and the Orthopaedic Research and Education Foundation (OREF) at the 2018 Annual Meeting of the American Academy of Orthopaedic Surgeons.

    This year’s award winners have made a major impact to research in the areas of:

    • Hip joint degeneration
    • Anterior cruciate ligament reconstruction
    • Tendon healing and remodeling
    • Use of adult stem cells for musculoskeletal tissue repair

    Understanding the Link Between Cam Morphology and Joint Degeneration

    Paul E. Beaulé, MD, FRCSC, professor and head of the Division of Orthopaedic Surgery in the Department of Surgery at The Ottawa Hospital and the University of Ottawa, received the 2018 Kappa Delta Elizabeth Winston Lanier Award for his research identifying the origins of cam morphology (pistol grip deformity) in the hip and how it can lead to joint degeneration.

    The research was co-authored by George Grammatopoulos, MD, FRCS, PhD; Andrew Speirs, PhD; Geoffrey Ng, PhD; Gerd Melkus, PhD; Sasha Carsen, MD; Hanspeter Frei, PhD; Kawan Rakhra, MD; and Mario Lamontagne, PhD. Dr. Speirs and Dr. Frei work at Carleton University, and Dr. Carsen at the Children’s Hospital of Eastern Ontario.

    More than 28 million people in the US are estimated to have osteoarthritis, [1] and the hip is second most commonly affected area. [2] Osteoarthritis of the hip causes pain and mobility issues and often leads to total hip arthroplasty. Although early hip joint degeneration is common and pre-existing abnormal joint morphology is a risk factor, there was only an observed association between cam morphology and hip osteoarthritis, with inconsistent evidence to suggest causation.

    Through an extensive and coordinated multidisciplinary effort spanning more than a decade, Dr. Beaulé and his team have conducted research to determine whether cam morphology is a cause of premature cartilage degeneration, as well as to gain better insight into how bone supporting the cartilage might play a role. Their body of work examined several patient cohorts, including teenagers, to determine how cam morphology might develop. They investigated the influence of sporting activity, the anatomic factors associated with pain, and the evolution of the deformity in patients who were diagnosed in early adulthood. Setting the data against Hill’s criteria (strength, specificity, temporality, plausibility, biological gradient, experiment, consistency, coherence and analogy of findings), the researchers concluded that cam morphology is a cause of early hip osteoarthritis.

    “Winning the Kappa Delta award is a tremendous honor,” said Dr. Beaulé. “It shows the huge benefits and potential of collaboration with basic science researchers and other clinicians, spanning biomechanics, kinematics, and medical imaging. This research is helping the development of a risk profile so that we can one day provide individuals with both surgical and physical therapy programs to avoid worsening of hip pain and loss of motion and keep their hips healthy.”

    They team not only confirmed that cam morphology forms during skeletal maturation, but also that other factors – such as spino-pelvic motion and size and location of the deformity – were key determinants in the risk of articular damage. More important, surgical correction of the deformity provides pain relief while also reducing bone and cartilage loading. Although not all patients with cam morphology will develop joint degeneration, the team was able to characterize static and dynamic contributing factors.

    “One of the next phases of our research is to better understand what types of activities are [put patients] at higher risk of developing the cam morphology,” Dr. Beaulé said. “We also need to look at exercise programs that truly affect how the hip moves and how it may affect the arthritic process. Lastly, we need to develop the biomarkers, so we can have early detection before arthritic hip pain and cartilage damage begin and [can]intervene sooner.”

    Optimizing Anterior Cruciate Ligament Reconstruction Using Registry Data

    The 2018 OREF Clinical Research Award was presented to Gregory B. Maletis, MD, chief of orthopaedics at the Kaiser Baldwin Park Medical Facility in California and clinical professor of orthopaedic surgery in the Keck/USC School of Medicine, for his research titled, Optimizing Anterior Cruciate Ligament Reconstruction: Individualizing the Decision-Making Process Using Data from the Kaiser Permanente ACLR Registry.

    The research was co-authored by Tadashi T. Funahashi, MD, chief innovations and transformation officer at Kaiser Permanente and clinical professor of orthopaedic surgery at the University of California at Irvine, College of Medicine; Elizabeth W. Paxton, MA, director of the Kaiser Permanente National Implant Registries; and Maria C. S. Inacio, PhD, consulting epidemiologist at Kaiser Permanente, Surgical Outcomes and Analysis Department, SCPMG Clinical Analysis, and senior epidemiology research fellow at the University of South Australia.

    The number of annterior cruciate ligament (ACL) reconstruction procedures has been increasing since 1994, with a more significant increase in females and adolescents. [3,4] Although ACL reconstruction outcomes are successful, several studies have found that athletes were not able to return to sports at their previous level.

    The Kaiser Permanente ACL Reconstruction Registry (KPACLRR) was established in 2004 to examine clinical practice, patient outcomes, and safety and to improve treatment outcomes. Dr. Maletis and his team compiled 15 years’ worth of ACL reconstruction surgery data from 340 Kaiser Permanente sports medicine surgeons across the country.

    “We’ve been able to show that by collecting and analyzing the data, determining the different outcomes – both poor and good outcomes – and providing that information back to the surgeons, they have been able to make changes in their practice and show improvements in patient outcomes,” Dr. Maletis said. “One of the main findings was that certain grafts have higher and lower risks of revision. For instance, there are certain types of allografts that don’t perform as well, typically the more highly irradiated and chemically processed grafts.”

    The KPACLRR registered more than 39,300 cases, of which 36,186 were primary ACL reconstructions and 3,193 were revision ACL reconstructions. The registered cohort was made up of 63% males and 37% females, with a mean age of 29 years.

    The researchers found that patients who were less than 21 years old had a 7.76 times higher risk of revision than those over 40 years old, and that graft type, gender, BMI, and race were associated with the risk of revision in this age group. Additionally, graft type played a significant role in the risk of revision surgery, with allografts having a higher risk of revision in age groups 40 years old and younger.

    As a result of the collective body of evidence, a risk calculator was developed to help predict the probability of graft survival based on specific patient characteristics, including age, type of sport, BMI and graft type. The risk calculator is now publicly available here.

    Promoting Effective Tendon Healing and Remodeling

    Nelly Andarawis-Puri, PhD, was presented with the 2018 Kappa Delta Young Investigator Award for her research in tendon disease or injury and the healing response.

    Dr. Andarawis-Puri is a Clare Boothe Luce assistant professor at Cornell University, Nancy and Peter Meinig Family Investigator in the Life Sciences department and adjunct assistant scientist at the Hospital for Special Surgery in New York. Evan Flatow, MD, Lasker professor of orthopaedic surgery and president of Mount Sinai West in New York, co-authored the research.

    Tendon injuries, disease and tears are very common, but understanding how tendons rupture is largely unknown, leading to limited healing and the inability to restore tendons back to a normal state. [5] Small tendon tears often form into larger, less manageable tears, [6,7] resulting in poor outcomes. Dr. Andarawis-Puri’s multidisciplinary research used animal models to investigate the mechanisms of damage accumulation that lead to a tendon injury and the mechanisms that cause effective scarless tendon healing.

    “The structure of the tendon has everything to do with the capacity to function,” said Dr. Andarawis-Puri. “The overall failure rate in tendon repair is high because patients heal with scaring, which doesn’t have mechanical integrity. No matter how far we advance in surgical techniques, if we’re working with scar tissue, it will always haunt us. However, if we can modify the structure or recreate an environment for the cell that is needed for remodeling, then we can produce better outcomes.”

    Dr. Andarawis-Puri and her team developed a model to understand how damage accumulates and leads to tendon injuries and to replicate scarless tendon healing after onset of rupture. The research found that damage begins to accumulate even from just 1 instance of sub-rupture fatigue loading, which was unexpected. Applying 1 bout of moderate-level fatigue loading – comparable to 1 intense bout of exercise by a middle-aged, untrained individual – led to tendon fatigue that didn’t recover until at least 6 weeks out, increasing the risk of tendon rupture. Dr. Andarawis-Puri emphasized that, as investigators still have not determined how tendons heal without forming scar, more research needs to be conducted.

    The Use of Adult Stem Cells in Musculoskeletal Tissue Repair

    The 2018 Kappa Delta Ann Doner Vaughn Award was presented to Johnny Huard, PhD, for his research on the use of adult stem cells, blood vessels, and angiogenesis in musculoskeletal repair.

    A previous Kappa Delta Young Investigator Award winner, Dr. Huard is a distinguished professor and vice chair for research in the Department of Orthopedic Surgery at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), director of the Center for Tissue Engineering and Aging Research at the Brown Foundation Institute for Molecular Medicine, and the chief scientific officer and director of the Center for Regenerative Sports Medicine at the Steadman Philippon Research Institute in Vail, Colorado. His research over the past 25 years has focused on gene and cell therapy in the treatment of musculoskeletal injuries and diseases.

    “Winning this award means that what my team and I are doing is important in the orthopaedic field and has value,” said Dr. Huard. “Dr. Freddie H Fu and Dr. Morey Moreland, who passed away in 2011, took me under their wings when I went to the University of Pittsburgh. They created a collaborative environment between scientists and clinicians, which has been key in my research and moving it into the clinical arena.”

    Each year, there are more than 20 million musculoskeletal injuries in the US, costing the healthcare system $150 billion. [8] Although some musculoskeletal injuries can repair spontaneously, the ability for the body to repair itself can be hindered by scar tissue, inflammation, and the degree of damage to surrounding tissues. [9]

    In the mid-1990s, Dr. Huard and his research team worked on muscle cell transplantation for Duchenne muscular dystrophy (DMD), in particular, the transplantation of normal myoblasts into muscles that lacked dystrophin.

    Ninety-nine percent of the cells weren’t surviving the implantation, so his team began to investigate the 1% of cells that survived post-implantation. The cells that survived post-implantation also displayed stem cell characteristics and were termed muscle-derived stem cells (MDSCs). These cells have been studied to improve the healing of numerous tissue types, including bone, articular cartilage, peripheral nerves, and ligaments, and they are currently being utilized in 2 clinical trials for stress urinary incontinence (phase II clinical trial) and myocardial infarction (phase I clinical trial).

    Based on this initial research, Dr. Huard and collaborators have begun to explore the origin of these cells and show they come from blood vessel walls. His research has also shown that promoting angiogenesis and the implication of blood vessel-derived cells in various tissue repair such as the anterior cruciate ligament (ACL) and meniscal repair. Although current ACL reconstruction methods are successful, recent studies have shown that normal knee structure and function are fully restored only 37% of the time. [10] As some of the musculoskeletal tissues have limited healing capacity, Dr. Huard believes that the use of adult stem cells may accelerate the healing process and reduce recovery time after injuries.

    “We are trying to give orthopaedic surgeons new technology to allow patients to heal faster and better through the use of adult stem cells,” said Dr. Huard. “If we inject stem cells into the joint fluid, we can decrease ACL recovery time by 1 month. Stem cell delivery wrapped around the tendon graft heals even faster than when stem cells are injected into the joint fluid.”

    About the Kappa Delta Awards

    In 1947, at its golden anniversary, the Kappa Delta Sorority established the Kappa Delta Research Fellowship in Orthopaedics, the first award ever created to honor achievements in the field of orthopaedic research. The first annual award, a single stipend of $1,000, was made available to the Academy in 1949 and presented at the AAOS meeting in 1950. The Kappa Delta Awards have been presented by the Academy to persons who have performed research in orthopaedic surgery that is of high significance and impact.

    The sorority has since added 2 more awards and increased the award amounts to $20,000 each. Two awards are named for the sorority national past presidents who were instrumental in the creation of the awards: Elizabeth Winston Lanier and Ann Doner Vaughn. The third is known as the Young Investigator Award.

    The fourth award, also providing $20,000, is the OREF Clinical Research Award. Established in 1995, the award recognizes outstanding clinical research related directly to musculoskeletal disease or injury. All submitted manuscripts are reviewed, graded, and selected by the American Academy of Orthopaedic Surgeons’ Research Development Committee.


    1. American Academy of Orthopaedic Surgeons. Osteoarthritis of the Hip. https://orthoinfo.aaos.org/en/diseases–conditions/osteoarthritis-of-the-hip/. Accessed 1/30/18.
    2. Orthopaedics and Sports Medicine, University of Washington. Osteoarthritis of the Hip. http://www.orthop.washington.edu/?q=patient-care/articles/hip/osteoarthritis-of-the-hip-hip-arthritis.html
    3. Buller LT, Best MJ, Baraga MG, Kaplan LD. Trends in anterior cruciate ligament reconstruction in the United States. Orthop J Sports Med. 2015;23(1):2325967114563664.
    4. Csintalan RP, Inacio MC, Funahashi TT. 2008. Incidence rate of anterior cruciate ligament reconstructions. Perm J. 2008;12(3):17-21
    5. Kovacevic D, Rodeo SA. Biological augmentation of rotator cuff tendon repair. CORR. 2008; 66:622-633.
    6. Kim HM, Dahiya N, Teefey SA, et al. Relationship of tear size and location to fatty degeneration of the rotator cuff. JBJS. 2010; 2:829-839.
    7. Matthews TJ, Hand GC, Rees JL, et al. Pathology of the torn rotator cuff tendon. Reduction in potential for repair as tear size increases. J Bone Joint Surg Br. 2006;88:489-495
    8. Jacobs JJ. The Burden of Musculoskeletal Diseases in the United States. 2nd ed Ch. 6. American Academy of Orthopaedic Surgeons; 2011. pp. 129–179.
    9. Evans CH, Huard J. Gene therapy approaches to regenerating the musculoskeletal system. Nat Rev Rheumatol. 2015 Apr; 11(4):234-242.
    10. Grimm NL, Jacobs JC, Jr., Kim J, et al. Anterior Cruciate Ligament and Knee Injury Prevention Programs for Soccer Players: A Systematic Review and Meta-analysis. Am J Sports Med. 2015 Aug;43(8):2049-56.